« Back to Record
Lebbe, C., Dutriaux, C., Lesimple, T., Kruit, W. H., Kerger, J., Thomas, L., Guillot, B., De Braud, F. D., Garbe, C., Grob, J. J., Loquai, C., Ferraresi, V., Robert, C., Vasey, P., Conry, R., Isaacs, R., Espinosa, E., Schueler, A., Massimini, G., & Dreno, B. (2020). Pimasertib versus dacarbazine in patients with unresectable NRAS-mutated cutaneous melanoma: Phase II, randomized, controlled trial with crossover. Cancers (Basel), 12(7), 1727, 1-11. doi:10.3390/cancers12071727
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/311520



